| 产品名称: | Neisseria weaveri Andersen et al. |
|---|---|
| 商品货号: | TS166485 |
| Strain Designations: | CDC 8142 |
| Isolation: | Dog bite wound, New York, NY |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®: | no |
| Type Strain: | yes |
| Medium: | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions: | Temperature: 25°C Atmosphere: Aerobic |
| Name of Depositor: | BM Andersen |
| Chain of Custody: | ATCC |
| References: | Holmes B, et al. Neisseria weaveri sp. nov. (formerly CDC group M-5), from dog bite wounds of humans. Int. J. Syst. Bacteriol. 43: 687-693, 1993. PubMed: 8240951 Validation list no. 47. Int. J. Syst. Bacteriol. 43: 864-865, 1993. |
| Cross References: | Nucleotide (GenBank) : AX110024 Sequence 757 from Patent WO0123604. Nucleotide (GenBank) : AJ228772 Neisseria weaveri 23S rRNA gene, partial. Nucleotide (GenBank) : AJ247250 Neisseria weaveri 16S rRNA gene, partial. Nucleotide (GenBank) : AF205579 Neisseria weaveri aspartate b-semialdehyde dehydrogenase gene, partial cds. |